Webinar: Injecting Neural Stem Cells into ALS Patients: Results of a Phase 1 Trial | Jonathan Glass

Title: Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS:  Results of a Phase I Trial in 12 Patients
Speaker: Jonathan D. Glass, M.D.
Professor, Neurology and Pathology, Emory University School of Medicine

Presented April 15, 2013

This presentation was part of the webinar event, "Clinical Trials: Moving Stem Cell based Therapies to the Clinic - Presentations from FDA and Leading Experts" hosted by CIRM and the Regenerative Medicine Consortium

The focus of this webinar is on the Lessons Learned from IND/Phase I trials including overcoming the challenges, and addressing the regulatory issues, as stem cell based therapies move towards the clinic.

To learn more about CIRM-funded progress toward therapies, click here.

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog